Pathologic hepatic Tc-99m-MDP uptake in polyostotic fibrous dysplasia
dc.authorid | Ertem, Kadir/0000-0002-8892-494X | |
dc.authorwosid | yagmur, cengiz/HQZ-3472-2023 | |
dc.authorwosid | Ertem, Kadir/ABG-9780-2020 | |
dc.contributor.author | Kekilli, E | |
dc.contributor.author | Yagmur, C | |
dc.contributor.author | Kuzucu, A | |
dc.contributor.author | Soysal, O | |
dc.contributor.author | Cikim, AS | |
dc.contributor.author | Ertem, K | |
dc.date.accessioned | 2024-08-04T20:13:38Z | |
dc.date.available | 2024-08-04T20:13:38Z | |
dc.date.issued | 2004 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Fibrous dysplasia of bone is a congenital, sporadic developmental disorder characterized by immature fibrous connective tissue and bone deformities. Hepatic Tc-99m-MDP uptake is a rare, serendipitous finding during bone scanning studies. The present patient was a 25-year-old male who had severe polyostotic fibrous dysplasia. On Tc-99m-MDP (methylene diphosphonate) bone scintigraphy, increased activity accumulations were seen on multiple ribs, vertebrae and base of the cranium. In addition, diffuse increased pathologic uptake of Tc-99m-MDP in the liver was shown. Intravenous pamidronate was administered monthly for two months. In the third week of the last administration Tc-99m-MDP bone scintigraphy was performed again, but despite sustained bone involvement, pathologic hepatic uptake was not seen on the scan. We thought that pathologic hepatic Tc-99m-MDP accumulation, may be related to the formation and aggregation of calcium oxalate and phosphate crystals which improved with pamidromat treatment. | en_US |
dc.identifier.doi | 10.1007/BF02984586 | |
dc.identifier.endpage | 630 | en_US |
dc.identifier.issn | 0914-7187 | |
dc.identifier.issn | 1864-6433 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.pmid | 15586638 | en_US |
dc.identifier.scopus | 2-s2.0-10044276208 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 627 | en_US |
dc.identifier.uri | https://doi.org/10.1007/BF02984586 | |
dc.identifier.uri | https://hdl.handle.net/11616/93751 | |
dc.identifier.volume | 18 | en_US |
dc.identifier.wos | WOS:000225205600011 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Annals of Nuclear Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | fibrous dysplasia | en_US |
dc.subject | hepatic | en_US |
dc.subject | extra-osseous | en_US |
dc.title | Pathologic hepatic Tc-99m-MDP uptake in polyostotic fibrous dysplasia | en_US |
dc.type | Article | en_US |